Physician profile
Simone M Chang
NPI 1588010953
$2,328.09
in general payments reported to CMS, 2019-2025
19 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $218 · 2021: $1,090 · 2022: $285 · 2023: $333 · 2024: $141 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $302.85 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $260.20 | 2025 | |
| Incyte Corporation | $236.44 | 2020-2021 | |
| Amgen INC. | $233.94 | 2021 | |
| Rigel Pharmaceuticals, INC. | $171.75 | 2021 | |
| Fennec Pharmaceuticals, INC. | $156.52 | 2023 | Pedmark |
| Genzyme Corporation | $127.21 | 2021 | |
| Adaptive Biotechnologies Corporation | $126.84 | 2021 | |
| Global Blood Therapeutics, INC. | $110.49 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $104.58 | 2022 | |
| Servier Pharmaceuticals LLC | $98.58 | 2022-2024 | |
| Pfizer INC. | $98.43 | 2024 | |
| Beigene USA, INC. | $96.41 | 2021 | |
| Mirati Therapeutics, INC. | $64.34 | 2023 | Krazati |
| Takeda Pharmaceuticals U.S.A., INC. | $52.77 | 2022-2023 | Elaprase, Advate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $35.16 | 2023 | Stealthstation S8 Platform |
| Tempus Ai, INC | $17.52 | 2024 | |
| Horizon Therapeutics Plc | $17.49 | 2022 | |
| Novo Nordisk INC | $16.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.